Bausch Health Companies Inc. (BHC) stock: key figures, P/E, revenue and dividend
Health Care · Canada · ISIN CA0717341071
Bausch Health Companies Inc. financials
| Fiscal year | 2025 |
|---|---|
| Revenue | 10.27 bn USD |
| Operating income | 1.81 bn USD |
| EBIT | 1.92 bn USD |
| Net income | 157.00 m USD |
| Diluted EPS – continuing operations | 0.42 USD |
Full history since 1993, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About Bausch Health Companies Inc.
Bausch Health Companies Inc. operates as a diversified specialty pharmaceutical and medical device company. It operates through five segments: Salix, International, Solta Medical, Diversified, and Bausch + Lomb. The company develops, manufactures, and markets products primarily in the therapeutic areas of gastroenterology, hepatology, neurology and dermatology, generic and branded generic pharmaceuticals, dentistry products, over-the-counter products, aesthetic medical devices, and eye health. The company sells its products in the United States, China, Canada, Poland, Mexico, France, South Korea, Russia, Japan, Germany, the United Kingdom, Spain, Italy, and internationally. The company was formerly known as Valeant Pharmaceuticals International, Inc. and changed its name to Bausch Health Companies Inc. in July 2018. Bausch Health Companies Inc. is headquartered in Laval, Canada.
More stocks
- NEWMARK GROUP, INC. (NMRK)
- ONESPAWORLD HOLDINGS Ltd (OSW)
- Zhefu Holding Group Co Ltd (002266.SZ)
- Veidekke ASA (VEI.OL)
- Jiangsu Boqian New Materials Stock Co Ltd (605376.SS)
- IDEAYA Biosciences, Inc. (IDYA)
- Addsino Co Ltd (000547.SZ)
- NSK Ltd (6471.T)
- Betta Pharmaceuticals Co Ltd (300558.SZ)
- Jilin Aodong Pharmaceutical Group Co Ltd (000623.SZ)
- Novoray Corporation (688300.SS)
- AXT INC (AXTI)
Not investment advice. All data without warranty, price as of 02.11.2026. Details in the risk notice.